Lasix (Furosemide)

Furosemide blocks the Na⁺/K⁺/2Cl⁻ cotransporter in the thick ascending limb of the loop of Henle. This inhibition reduces reabsorption of sodium, chloride, and water, leading to increased urinary output. The resulting loss of fluid and electrolytes decreases extracellular fluid volume and plasma volume, alleviating edema and lowering blood pressure.

The appropriate dose of Lasix is individualized by the prescribing clinician based on the patient’s underlying condition, severity of edema or hypertension, renal function, and response to therapy. Dosage adjustments may be needed for elderly patients, those with impaired kidney function, or when used in combination with other diuretics.

Safety data for furosemide in pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case carefully and discuss potential risks before prescribing.

To order Lasix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain if required) and any necessary import documentation.

Lasix (furosemide) is a loop diuretic, acting on the ascending limb of the loop of Henle, and is more potent than thiazide diuretics, which act on the distal convoluted tubule. Loop diuretics are preferred for rapid, substantial fluid removal in conditions like severe edema, while thiazides are often used for milder hypertension and fluid retention.

Store Lasix injection at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and avoid freezing. Ensure the container is tightly sealed to maintain sterility until use.

Lasix is supplied as a sterile injection for intramuscular (IM) or intravenous (IV) administration. The healthcare professional selects the route based on the clinical situation, and the medication is typically diluted in an appropriate carrier fluid before infusion or injected directly into muscle tissue.

Serious risks include ototoxicity (hearing loss or tinnitus), severe electrolyte disturbances such as profound hypokalemia or hyponatremia, acute kidney injury, and marked hypotension. Patients should be monitored closely for these events, especially when high doses or rapid administration are used.

Lasix is contraindicated in patients with anuria (no urine output), known hypersensitivity to furosemide or other sulfonamides, and those with severe electrolyte imbalances that cannot be corrected. Caution is also advised for individuals with severe hepatic impairment, uncontrolled diabetes, or those taking other ototoxic medications.